TABLE 3.
Study design | Study population | Intervention2 | Control2 | Duration of intervention | Antioxidant or anti-inflammatory effect | Reference |
---|---|---|---|---|---|---|
RCT, parallel arm | Postmenopausal women (n = 40, completed) | 50 g/d DP consumption (n = 14, age = 68.5 y)100 g/d DP consumption (n = 13, age = 70.4 y) | 0 g/d DP consumption (n = 13, age = 71 y) | 6 mo | ↓Plasma TBARS in 50-g/d and 100-g/d DP groups↑Plasma TAC in 50-g/d DP group↑Plasma SOD activity in 50-g/d and 100-g/d DP groups↑Plasma GST activity in 50-g/d DP group↔Plasma CAT and GPX activities | (160) |
RCT, parallel arm | Postmenopausal women with osteopenia (n = 100, completed) | 100 g/d DP consumption (n = 55, age = 57.5 y) | 75 g/d dried apple consumption (n = 45, age = 55.6 y) | 3, 6, and 12 mo | ↓Serum CRP at 3 mo in DP group↔Serum CRP at 6 or 12 mo | (41) |
RCT, parallel arm | Postmenopausal women with osteopenia (n = 42, completed) | 50 g/d DP consumption (n = 16, age = 68.5 y)100 g/d DP consumption (n = 13, age = 70.4 y) | 0 g/d DP consumption (n = 13, age = 71 y) | 6 mo | ↔Serum CRP | (42) |
RCT, parallel arm | Postmenopausal women (n = 40, completed) | 50 g/d DP consumption (n = 14, age = 68.5 y)100 g/d DP consumption (n = 13, age = 70.4 y) | 0 g/d DP consumption (n = 13, age = 71 y) | 6 mo | ↓Plasma IL-6, TNF-α in 50-g/d DP group | (160) |
CAT, catalase; CRP, C-reactive protein; DP, dried plum; GPX, glutathione peroxidase; GST, glutathione S transferase; RCT, randomized controlled trial; SOD, superoxide dismutase; TAC, total antioxidant capacity; TBARS, thiobarbituric acid reactive substances; ↑, significant increase; ↓, significant decrease; ↔, no change.
Includes 500 mg calcium + 400 IU (10 mg) vitamin D3. Ages are means.